Bibliographic Details
| Title: |
A.6 INDIGO: a global, randomized, double-blinded, Phase 3 study of vorasidenib versus placebo in patients with grade 2 glioma with an IDH1/2 mutation (mIDH1/2). |
| Authors: |
Perry, JR, Mellinghoff, IK, van den Bent, M, Blumenthal, DT, Touat, M, Peters, KB, Clarke, J, Mendez, J, Yust-Katz, S, Mason, W, Ducray, F, Umemura, Y, Nabors, B, Holdhoff, M, Hottinger, AF, Arakawa, Y, Sepúlveda, J, Wick, W, Soffietti, R, Giglio, P, et al |
| Source: |
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2024 Supplement; Vol. 51. |
| Journal Info: |
Publisher: Cambridge University Press ISSN: 0317-1671 |
| Database: |
MEDLINE Ultimate |
